With a sturdy scientific-stage pipeline, Agenus harnesses a mix of proprietary antibody platforms, such as Retrocyte Show™ and SECANT®, and revolutionary mobile therapy methods, positioning alone being a important contributor during the biotechnology and immunotherapy arena.Our expenditure administration enterprise generates asset-dependent fees